
AVITA Medical, Inc.
RCELNasdaqCIK 1762303HealthcareFiscal year ends Dec 31
Reports and events: 160 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-11-0916:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-062036 |
| 2023-11-0916:07 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-062024 |
| 2023-10-2316:36 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-23-054644 |
| 2023-10-1809:07 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950170-23-053882 |
| 2023-10-0208:56 ET | 8-K | 8.01 Other events | 0000950170-23-050935 |
| 2023-08-1016:06 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-041304 |
| 2023-08-1016:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-041292 |
| 2023-06-2608:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-174497 |
| 2023-06-1619:51 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-168182 |
| 2023-06-0713:29 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-23-162334 |
| 2023-05-1620:43 ET | 8-K/A | 2.02 Results of operations | 0001193125-23-145360 |
| 2023-05-1216:01 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-143451 |
| 2023-05-1116:31 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-021310 |
| 2023-04-2112:14 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-109996 |
| 2023-04-1415:05 ET | DEF 14A | Proxy statementPeriod 2023-06-06 | 0001193125-23-101939 |
| 2023-03-2716:19 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-080474 |
| 2023-03-2217:26 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-076835 |
| 2023-03-2106:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-075191 |
| 2023-03-0816:06 ET | 8-K | 8.01 Other events | 0001193125-23-064487 |
| 2023-03-0216:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-058123 |
| 2023-02-2316:02 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001564590-23-002302 |
| 2023-02-1016:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-032567 |
| 2023-01-2019:43 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-011170 |
| 2022-12-2016:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-309133 |
| 2022-12-1416:06 ET | 8-K | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-304795 |
| 2022-11-1406:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-283537 |
| 2022-11-1016:33 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001564590-22-037402 |
| 2022-11-0916:54 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-281300 |
| 2022-10-1917:20 ET | DEF 14A | Proxy statementPeriod 2022-12-12 | 0001193125-22-265381 |
| 2022-09-3008:54 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-254959 |
| 2022-09-2216:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-249166 |
| 2022-09-1309:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-243345 |
| 2022-09-0209:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-237221 |
| 2022-08-3011:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-233755 |
| 2022-08-1213:21 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-219732 |
| 2022-08-1116:12 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001564590-22-029124 |
| 2022-07-2216:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-200015 |
| 2022-05-1716:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-152986 |
| 2022-05-1216:37 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001564590-22-019898 |
| 2022-05-1016:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-146250 |
| 2022-04-2912:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-131682 |
| 2022-04-2116:40 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-113106 |
| 2022-04-0516:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-096145 |
| 2022-03-2416:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-083864 |
| 2022-03-0911:33 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-070216 |
| 2022-03-0410:42 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-065361 |
| 2022-03-0112:43 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-060645 |
| 2022-02-2416:44 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-052218 |
| 2022-02-1816:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-046587 |
| 2022-02-0320:27 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-026067 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 21:29 ET. Listed shows no prices and gives no investment advice.